All News

Data suggest a substantial reliance on established therapies for polycythemia vera, despite access to all available treatment options.

How much progress have we made in developing therapies to treat this common childhood respiratory disorder?

Following some improvement, excess death rate returned to 1999 levels for Black men and 2005 levels for Black women.

The REFLECT Scoliosis Correction System from Globus Medical is intended to correct progressive scoliosis in pediatric patients while simultaneously maintaining stability and motion as well as allowing for future modulated growth.

Authors offered specific recommendations for improving publishing and adoption of algorithmic processes focused on type 2 diabetes (T2D) going forward.

The atrial fibrillation drug, asundexian, may provide protection from thrombotic events without a corresponding increase in bleeding risk.

The atrial fibrillation drug, asundexian, may provide protection from thrombotic events without a corresponding increase in bleeding risk.

Doing small spurts of exercise throughout the day provide numerous benefits.

Using a national database, data on medication purchases was collected, along with factors that may have influenced expenditures, such as new therapy availability, patent expirations, policy changes, and legislation.

The company that developed the treatment said it will benefit "millions" of patients.

Data from two phase 3 studies showed that brexpiprazole 2 mg or 3 mg doses significantly improved symptoms of agitation in patients with AAD.

Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.

There are only a few long-term treatments currently available for adolescents with moderate to severe AD.

Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.

Common treatments for acne are known to be unsafe for pregnant women, but alternative treatments exist that are safe for use; however, actual treatment patterns within this patient population are unclear.

A new CDC report on data collected by the Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder During Pregnancy, indicates that medication for opioid use disorder is more often given to individuals who are White, older, and have private insurance.

The brand-new treatment from Elanco is currently the only approved therapeutic solution proven to treat canine parvovirus.

Inhaled corticosteroids were observed to be associated with increases in rates of pneumonia and tuberculosis, according to a recent study.

A new study investigates whether GPT-4 can provide more in-depth analysis than medical professionals.

WHO ends COVID-19 public health emergency, privacy concerns around mental health apps, and astronomical interest with medical credit cards.

A recent clinical trial showed positive results from the selective neurokinin-1,3 receptor antagonist elinzanetant (Bayer) against menopausal vasomotor symptoms.

Despite having a highly differentiated clinical value proposition compared to branded, twice-nightly oxybates, Avadel is pricing Lumryz at $64.67 per gram or around $177,034 annually, which is on par with twice-nightly oxybate products that require chronic, middle-of-the-night awakening.

Lawmakers take on harm reduction, in-flight medical emergency kits are under review, and a new Alzheimer drug shows promise.

According to a recent study, the association between employment status and contraceptive use observed in a period before the Affordable Care Act (ACA) was not found after the ACA ended.

Both Democrats and Republicans voted to bring back the act that attempts to improve use of antibiotics

Though the Omicron variant caused the most symptoms in pediatric patients, there were no differences in adverse outcomes by COVID-19 variant.

The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.